Show simple item record

dc.contributor.authorNémeth, János
dc.contributor.authorTapasztó, Beáta
dc.contributor.authorAclimandos, Wagih A.
dc.contributor.authorKestelyn, Philippe
dc.contributor.authorJonas, Jost B.
dc.contributor.authorDe Faber, Jan-Tjeerd H. N.
dc.contributor.authorJanuleviciene, Ingrida
dc.contributor.authorGrzybowski, Andrzej
dc.contributor.authorNagy, Zoltán Zsolt
dc.contributor.authorPärssinen, Olavi
dc.contributor.authorGuggenheim, Jeremy A.
dc.contributor.authorAllen, Peter M.
dc.contributor.authorBaraas, Rigmor C.
dc.contributor.authorSaunders, Kathryn J
dc.contributor.authorFlitcroft, Daniel Ian
dc.contributor.authorGray, Lyle S.
dc.contributor.authorPolling, Jan Roelof
dc.contributor.authorHaarman, Annechien E. G.
dc.contributor.authorTideman, J. Willem L.
dc.contributor.authorWolffsohn, James Stuart
dc.contributor.authorWahl, Siegfried
dc.contributor.authorMulder, Jeroen A.
dc.contributor.authorSmirnova, Irina Yurievna
dc.contributor.authorFormenti, Marino
dc.contributor.authorRadhakrishnan, Hema
dc.contributor.authorResnikoff, Serge
dc.identifier.citationNémeth, J., Tapasztó, B., Aclimandos, W. A., Kestelyn, P., Jonas, J. B., De Faber, J.-T. H. N., Januleviciene, I., Grzybowski, A., Nagy, Z. Z., Pärssinen, O., Guggenheim, J. A., Allen, P. M., Baraas, R. C., Saunders, K. J., Flitcroft, D. I., Gray, L. S., Polling, J. R., Haarman, A. E. G., Tideman, J. W. L., Wolffsohn, J. S., Wahl, S., Mulder, J. A., Smirnova, I. Y., Formenti, M., Radhakrishnan, H. & Resnikoff, S. (2021). Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute. European Journal of Ophthalmology, 31(3), 853-883.en_US
dc.description.abstractThe prevalence of myopia is increasing extensively worldwide. The number of people with myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 billion by 2050, unless preventive actions and interventions are taken. The number of individuals with high myopia is also increasing substantially and pathological myopia is predicted to become the most common cause of irreversible vision impairment and blindness worldwide and also in Europe. These prevalence estimates indicate the importance of reducing the burden of myopia by means of myopia control interventions to prevent myopia onset and to slow down myopia progression. Due to the urgency of the situation, the European Society of Ophthalmology decided to publish this update of the current information and guidance on management of myopia. The pathogenesis and genetics of myopia are also summarized and epidemiology, risk factors, preventive and treatment options are discussed in details.en_US
dc.rightsNavngivelse-Ikkekommersiell 4.0 Internasjonal*
dc.titleUpdate and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Instituteen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.rights.holder© The Author(s) 2021.en_US
dc.source.journalEuropean Journal of Ophthalmologyen_US

Files in this item


This item appears in the following Collection(s)

Show simple item record

Navngivelse-Ikkekommersiell 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse-Ikkekommersiell 4.0 Internasjonal